van Akkooi ACJ - Search Results

1

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.

Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Among authors: van akkooi acj, van den eertwegh ajm. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.

2

Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's witness.

van Akkooi AC, Golab-Schwarz HD, Eggermont AM, van Geel AN. van Akkooi AC, et al. Eur J Cardiothorac Surg. 2006 Aug;30(2):408-10. doi: 10.1016/j.ejcts.2006.04.020. Epub 2006 Jul 7. Eur J Cardiothorac Surg. 2006. PMID: 16829108

3

Sentinel lymph-node false positivity in melanoma.

van Akkooi AC, de Wilt JH, Voit C, Verhoef C, Suciu S, Eggermont AM. van Akkooi AC, et al. Nat Clin Pract Oncol. 2008 Apr;5(4):E2. doi: 10.1038/ncponc1111. Nat Clin Pract Oncol. 2008. PMID: 18376421 No abstract available.

4

Detection of melanoma micrometastases in sentinel nodes - the cons.

de Wilt JH, van Akkooi AC, Verhoef C, Eggermont AM. de Wilt JH, et al. Surg Oncol. 2008 Sep;17(3):175-81. doi: 10.1016/j.suronc.2008.06.004. Epub 2008 Jul 9. Surg Oncol. 2008. PMID: 18617395 Review.

5

Impact of molecular staging methods in primary melanoma: reverse-transcriptase polymerase chain reaction (RT-PCR) of ultrasound-guided aspirate of the sentinel node does not improve diagnostic accuracy, but RT-PCR of peripheral blood does predict survival.

Voit CA, Schäfer-Hesterberg G, Kron M, van Akkooi AC, Rademaker J, Lukowsky A, Schoengen A, Schwürzer-Voit M, Sterry W, Krause M, Röwert-Huber J, Eggermont AM. Voit CA, et al. J Clin Oncol. 2008 Dec 10;26(35):5742-7. doi: 10.1200/JCO.2007.13.7653. Epub 2008 Nov 3. J Clin Oncol. 2008. PMID: 18981467

6

The Rotterdam criteria for sentinel node tumor load: the simplest prognostic factor?

van Akkooi AC, de Wilt JH, Verhoef C, Eggermont AM. van Akkooi AC, et al. J Clin Oncol. 2008 Dec 20;26(36):6011; author reply 6012. doi: 10.1200/JCO.2008.19.5420. Epub 2008 Nov 17. J Clin Oncol. 2008. PMID: 19018076 No abstract available.

7

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.

van Akkooi AC, Nowecki ZI, Voit C, Schäfer-Hesterberg G, Michej W, de Wilt JH, Rutkowski P, Verhoef C, Eggermont AM. van Akkooi AC, et al. Ann Surg. 2008 Dec;248(6):949-55. doi: 10.1097/SLA.0b013e31818fefe0. Ann Surg. 2008. PMID: 19092339

8

Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma?

Voit CA, van Akkooi AC, Schäfer-Hesterberg G, Schoengen A, Schmitz PI, Sterry W, Eggermont AM. Voit CA, et al. J Clin Oncol. 2009 Oct 20;27(30):4994-5000. doi: 10.1200/JCO.2008.19.0033. Epub 2009 Sep 8. J Clin Oncol. 2009. PMID: 19738131

9

Expert opinion in melanoma: the sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden.

van Akkooi AC, Spatz A, Eggermont AM, Mihm M, Cook MG. van Akkooi AC, et al. Eur J Cancer. 2009 Nov;45(16):2736-42. doi: 10.1016/j.ejca.2009.08.015. Epub 2009 Sep 18. Eur J Cancer. 2009. PMID: 19767199 Review.

10

Potential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up.

van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. van Akkooi AC, et al. Ann Surg Oncol. 2010 Feb;17(2):660-2; author reply 663-4. doi: 10.1245/s10434-009-0807-8. Ann Surg Oncol. 2010. PMID: 19921338 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page